InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Paul Sandland. Director active across 1 company, notably Dechra Pharmaceuticals PLC. Cumulatively, 7 disclosures have been logged. History available since 15 January 2024. The latest transaction was disclosed on 15 January 2024 (Purchase). Regulator: RNS (LSE). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Paul Sandland is a declarant connected to Dechra Pharmaceuticals PLC, where he is Director/PDMR. He has 7 filings in total, and across the 7 sampled recent filings these were purchases totaling EUR 29372, with no sales, between 2023-10-18 and 2024-01-15.